Moosig F, Schmalzing M, Aries PM, Henes J, Lamprecht P, Rech J, Witte T (2019)
Publication Type: Journal article
Publication year: 2019
Book Volume: 144
Pages Range: 595-600
Journal Issue: 9
DOI: 10.1055/a-0832-3563
To prevent serious complications such as permanent loss of vision and structural vascular damage, treatment must be initiated quickly in patients with giant-cell arteritis (GCA). So far, usually long-term corticosteroids in cumulative high dosages have been the standard therapy option. However, steroids are often insufficient to achieve adequate disease control and are associated with serious adverse events. Therefore, steroid-sparing therapy options are the focus of interest.
APA:
Moosig, F., Schmalzing, M., Aries, P.M., Henes, J., Lamprecht, P., Rech, J., & Witte, T. (2019). Actual Treatment Options for Giant Cell Arteritis. Deutsche Medizinische Wochenschrift, 144(9), 595-600. https://doi.org/10.1055/a-0832-3563
MLA:
Moosig, Frank, et al. "Actual Treatment Options for Giant Cell Arteritis." Deutsche Medizinische Wochenschrift 144.9 (2019): 595-600.
BibTeX: Download